Scolaris Content Display Scolaris Content Display

Trasplante de células madre alogénicas versus tratamiento convencional para el linfoma de linfocitos T cutáneo primario avanzado

Contraer todo Desplegar todo

Referencias

References to studies excluded from this review

Ir a:

Alaibac 2005 {published data only}

Alaibac M, Berti E, Pigozzi B, Chiarion V, Aversa S, Marino F, et al. High‐dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis‐like T‐cell lymphoma. Journal of the American Academy of Dermatology 2005;52(5 Suppl 1):121‐3. [PUBMED: 15858508]

Bertz 2002 {published data only}

Bertz H, Illerhaus G, Veelken H, Finke J. Allogeneic hematopoetic stem‐cell transplantation for patients with relapsed or refractory lymphomas: comparison of high‐dose conventional conditioning versus fludarabine‐based reduced‐intensity regimens. Annals of Oncology 2002;13(1):135‐9. [PUBMED: 11863095]

Burt 2000 {published data only}

Burt RK, Guitart J, Traynor A, Link C, Rosen S, Pandolfino T, et al. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft‐versus‐tumor effect. Bone Marrow Transplantation 2000;25(1):111‐3. [PUBMED: 10654025]

Chanan‐Khan 2004 {published data only}

Chanan‐Khan A, Islam T, Alam A, Miller KC, Gibbs J, Barcos M, et al. Long‐term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti‐CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T‐cell non‐Hodgkin's lymphoma. Leukemia & Lymphoma 2004;45(8):1673‐5. [PUBMED: 15370223]

Corradini 2006 {published data only}

Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P, et al. Long‐term follow‐up of patients with peripheral T‐cell lymphomas treated up‐front with high‐dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006;20(9):1533‐8. [PUBMED: 16871285]

Cudillo 2009 {published data only}

Cudillo L, Cerretti R, Baliva G, De Angelis G, Postorino M, Picardi A, et al. Sézary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion. Bone Marrow Transplantation 2009;43(4):347‐8. [PUBMED: 18850017]

Duarte 2008 {published data only}

Duarte RF, Schmitz N, Servitje O, Sureda A. Haematopoietic stem cell transplantation for patients with primary cutaneous T‐cell lymphoma. Bone Marrow Transplantation 2008;41(7):597‐604. [PUBMED: 18176611]

Duarte 2010 {published data only}

Duarte RF, Canals C, Onida F, Gabriel IH, Arranz R, Arcese W, et al. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology 2010;28(29):4492‐9. [PUBMED: 20697072]

Duvic 2010 {published data only}

Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, et al. Total skin electron beam and non‐myeloablative allogeneic hematopoietic stem‐cell transplantation in advanced mycosis fungoides and Sézary syndrome. Journal of Clinical Oncology 2010;28(14):2365‐72. [PUBMED: 20351328]

Fijnheer 2003 {published data only}

Fijnheer R, Sanders CJ, Canninga MR, de Weger RA, Verdonck LF. Complete remission of a radiochemotherapy‐resistant cutaneous T‐cell lymphoma with allogeneic non‐myeloablative stem cell transplantation. Bone Marrow Transplantation 2003;32(3):345‐7. [PUBMED: 12858211]

Gabriel 2007 {published data only}

Gabriel IH, Olavarria E, Jones RR, Whittaker S, Chaidos A, Apperley JF. Graft versus lymphoma effect after early relapse following reduced‐intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides. Bone Marrow Transplantation 2007;40(4):401‐3. [PUBMED: 17589536]

Ghobrial 2005 {published data only}

Ghobrial IM, Weenig RH, Pittlekow MR, Qu G, Kurtin PJ, Ristow K, et al. Clinical outcome of patients with subcutaneous panniculitis‐like T‐cell lymphoma. Leukemia & Lymphoma 2005;46(5):703‐8. [PUBMED: 16019507]

Guitart 2002 {published data only}

Guitart J, Wickless SC, Oyama Y, Kuzel TM, Rosen ST, Traynor A, et al. Long‐term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T‐cell lymphoma. Archives of Dermatology 2002;138(10):1359‐65. [PUBMED: 12374543]

Hamadani 2008 {published data only}

Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Blum KA, et al. Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft‐versus‐T cell lymphoma effect. Biology of Blood & Marrow Transplantation 2008;14(4):480‐3. [PUBMED: 18342792]

Hathaway 2007 {published data only}

Hathaway T, Subtil A, Kuo P, Foss F. Efficacy of denileukin diftitox in subcutaneous panniculitis‐like T‐cell lymphoma. Clinical Lymphoma & Myeloma 2007;7(8):541‐5. [PUBMED: 18021473]

Herbert 2004 {published data only}

Herbert KE, Spencer A, Grigg A, Ryan G, McCormack C, Prince HM. Graft‐versus‐lymphoma effect in refractory cutaneous T‐cell lymphoma after reduced‐intensity HLA‐matched sibling allogeneic stem cell transplantation. Bone Marrow Transplantation 2004;34(6):521‐5. [PUBMED: 15286686]

Hoff 2008 {published data only}

Hoff NP, Groffik A, Mota R, Pippirs U, Hengge UR, Kobbe G, et al. Successful use of allogeneic stem cell transplantation for treatment‐refractory mycosis fungoides [Erfolgreicher Einsatz einer allogenen Stammzelltransplantation bei therapierefraktärer Mycosis fungoides]. Hautarzt 2008;59(10):779‐82. [PUBMED: 18773178]

Horwitz 2008 {published data only}

Horwitz SM, Olsen EA, Duvic M, Porcu P, Kim YH. Review of the treatment of mycosis fungoides and Sézary syndrome: a stage‐based approach. Journal of the National Comprehensive Cancer Network 2008;6(4):436‐42. [PUBMED: 18433609]

Ichii 2006 {published data only}

Ichii M, Hatanaka K, Imakita M, Ueda Y, Kishino B, Tamaki T. Successful treatment of refractory subcutaneous panniculitis‐like T‐cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA‐mismatched sibling donor. Leukemia & Lymphoma 2006;47(10):2250‐2. [PUBMED: 17071503]

Kahata 2008 {published data only}

Kahata K, Hashino S, Takahata M, Fujisawa F, Kondo T, Kobayashi S, et al. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced‐intensity conditioning. Acta Haematologica 2008;120(1):14‐8. [PUBMED: 18716396]

Knobler 2001 {published data only}

Knobler R, Girardi M. Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas. Annals of the New York Academy of Sciences 2001;941:123‐38. [PUBMED: 11594566]

Knobler 2002 {published data only}

Knobler E, Warmuth I. Extracorporeal photochemotherapy: a case report and update. Cutis 2002;69(2):119‐23. [PUBMED: 11868976]

Koch 2009 {published data only}

Koch R, Jaffe ES, Mensing C, Zeis M, Schmitz N, Sander CA. Cutaneous gamma/delta T‐cell lymphoma [Primär kutanes Gamma/Delta‐T‐Zell‐Lymphom]. Journal der Deutschen Dermatologischen Gesellschaft 2009;7(12):1065‐7. [PUBMED: 19694889]

Majhail 2005 {published data only}

Majhail NS, Burns LJ. Hematopoietic stem cell transplantation in the treatment of peripheral T‐cell lymphomas. Current Hematology Reports 2005;4(4):252‐9. [PUBMED: 16009039]

Masood 2002 {published data only}

Masood N, Russell KJ, Olerud JE, Sabath DE, Sale GE, Doney KC, et al. Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation. Journal of the American Academy of Dermatology 2002;47(1):140‐5. [PUBMED: 12077596]

Molina 1999 {published data only}

Molina A, Nademanee A, Arber DA, Forman SJ. Remission of refractory Sézary syndrome after bone marrow transplantation from a matched unrelated donor. Biology of Blood & Marrow Transplantation 1999;5(6):400‐4. [PUBMED: 10595818]

Molina 2005 {published data only}

Molina A, Zain J, Arber DA, Angelopolou M, O'Donnell M, Murata‐Collins J, et al. Durable clinical, cytogenetic and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sézary syndrome and mycosis fungoides. Journal of Clinical Oncology 2005;23(25):6163‐71. [PUBMED: 16135483]

Mukai 2003 {published data only}

Mukai HY, Okoshi Y, Shimizu S, Katsura Y, Takei N, Hasegawa Y, et al. Successful treatment of a patient with subcutaneous panniculitis‐like T‐cell lymphoma with high‐dose chemotherapy and total body irradiation. European Journal of Haematology 2003;70(6):413‐6. [PUBMED: 12756026]

Nakahashi 2009 {published data only}

Nakahashi H, Tsukamoto N, Yamane A, Saitoh T, Uchiumi H, Handa H, et al. Autologous peripheral blood stem cell transplantation to treat CHOP‐refractory aggressive subcutaneous panniculitis‐like T cell lymphoma. Acta Haematologica 2009;121(4):239‐42. [PUBMED: 19556752]

Nishio 2000 {published data only}

Nishio M, Koizumi K, Endo T, Takashima H, Haseyama Y, Fujimoto K, et al. Effective high‐dose chemotherapy combined with CD34+‐selected autologous peripheral blood stem cell transplantation in a patient with cutaneous CD30‐negative large T cell lymphoma. Bone Marrow Transplantation 2000;25(12):1315‐7. [PUBMED: 10871740]

Okada 2010 {published data only}

Okada S, Nannya Y, Ota S, Takazawa Y, Yamamoto G, Kumano K, et al. Cutaneous T‐cell lymphoma (mycosis fungoides) relapsed with different immunological phenotype after bone marrow transplant. British Journal of Dermatology 2010;162(1):229‐30. [PUBMED: 19903173]

Perez‐Persona 2006 {published data only}

Perez‐Persona E, Mateos‐Mazon JJ, Lopez‐Villar O, Arcos MJ, Encinas C, Graciani IF, et al. Complete remission of subcutaneous panniculitic T‐cell lymphoma after allogeneic transplantation. Bone Marrow Transplantation 2006;38(12):821‐2. [PUBMED: 17057727]

Poligone 2010 {published data only}

Poligone B, Heald P. Innovative therapy of cutaneous T‐cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustard. Dermatologic Clinics 2010;28(3):501‐10. [PUBMED: 20510760]

Rook 1994 {published data only}

Rook AH, Wolfe JT. Role of extracorporeal photopheresis in the treatment of cutaneous T‐cell lymphoma, autoimmune disease, and allograft rejection. Journal of Clinical Apheresis 1994;9(1):28‐30. [PUBMED: 8195109]

Russell‐Jones 2001 {published data only}

Russell‐Jones R, Child F, Olavarria E, Whittaker S, Spittle M, Apperley J. Autologous peripheral blood stem cell transplantation in tumor‐stage mycosis fungoides: predictors of disease‐free survival. Annals of the New York Academy of Sciences 2001;941:147‐54. [PUBMED: 11594568]

Shustov 2010 {published data only}

Shustov AR, Gooley TA, Sandmaier BM, Shizuru J, Sorror ML, Sahebi F, et al. Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T‐cell and natural killer‐cell lymphomas. British Journal of Haematology 2010;150(2):170‐8. [PUBMED: 20507311]

Soligo 2003 {published data only}

Soligo D, Ibatici A, Berti E, Morandi P, Longhi E, Venegoni L, et al. Treatment of advanced mycosis fungoides by allogeneic stem‐cell transplantation with a nonmyeloablative regimen. Bone Marrow Transplantation 2003;31(8):663‐6. [PUBMED: 12692606]

Taylor 1992 {published data only}

Taylor A, Gasparro FP. Extracorporeal photochemotherapy for cutaneous T‐cell lymphoma and other diseases. Seminars in Hematology 1992;29(2):132‐41. [PUBMED: 1594945]

Tsuji 2010 {published data only}

Tsuji H, Wada T, Murakami M, Kashiwagi T, Ito Y, Ishida‐Yamamoto A, et al. Two cases of mycosis fungoides treated by reduced‐intensity cord blood transplantation. Journal of Dermatology 2010;37(12):1040‐5. [PUBMED: 21083707]

Wu 2009 {published data only}

Wu PA, Kim YH, Lavori PW, Hoppe RT, Stockerl‐Goldstein KE. A meta‐analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome. Biology of Blood & Marrow Transplantation 2009;15(8):982‐90. [PUBMED: 19589488]

Zain 2010 {published data only}

Zain J, Kaminetzky D, O'Connor OA. Emerging role of epigenetic therapies in cutaneous T‐cell lymphomas. Expert Review of Hematology 2010;3(2):187‐203. [PUBMED: 21083462]

Additional references

Ir a:

Aoudjhane 2005

Aoudjhane M, Labopin M, Gorin NC, Shimoni A, Ruutu T, Kolb HJ, et al. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia 2005;19(12):2304‐12. [PUBMED: 16193083]

Apisarnthanarax 2002

Apisarnthanarax N, Talpur R, Duvic M. Treatment of cutaneous T cell lymphoma: current status and future directions. American Journal of Clinical Dermatology 2002;3(3):193‐215. [PUBMED: 11978140]

Dearden 2007

Dearden C. Is there a role for hemopoietic stem‐cell transplantation in CTCL?. Oncology (Williston Park, N.Y.) 2007;21(2 Suppl 1):24‐8. [PUBMED: 17474356]

Deeks 2011

Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.

Feinstein 2001

Feinstein L, Storb R. Nonmyeloablative hematopoietic cell transplantation. Current Opinion in Oncology 2001;13(2):95‐100. [MEDLINE: 11224706]

Foss 2004

Miller KB, Roberts TF, Chan G, Schenkein DP, Lawrence D, Sprague K, et al. A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft‐versus‐host disease. Bone Marrow Transplant 2004;33(9):881‐9. [PUBMED: 14990986]

Gardner 2009

Gardner JM, Evans KG, Musiek A, Rook AH, Kim EJ. Update on treatment of cutaneous T‐cell lymphoma. Current Opinion in Oncology 2009;21(2):131‐7. [PUBMED: 19532014]

Giralt 2001

Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C, et al. Melphalan and purine analog‐containing preparative regimens: reduced‐intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001;97(3):631‐7. [PUBMED: 11157478]

Higgins 2011a

Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Higgins 2011b

Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Higgins 2011c

Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Hoff 2010

Hoff NP, Bruch‐Gerharz D. The role of hematopoietic stem‐cell transplantation in cutaneous T‐cell lymphoma. Giornale Italiano di Dermatologia e Venereologia 2010;145(3):345‐59. [PUBMED: 20461043]

Introcaso 2008

Introcaso CE, Leber B, Greene K, Ubriani R, Rook AH, Kim EJ. Stem cell transplantation in advanced cutaneous T‐cell lymphoma. Journal of the American Academy of Dermatology 2008;58(4):645‐9. [PUBMED: 18258335]

Karanes 2008

Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, et al. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biology of Blood and Marrow Transplantation 2008;14(9 Suppl):8‐15. [PUBMED: 18721775]

Kim 2003

Kim YH, Liu HL, Mraz‐Gernhard S, Varghese A, Hoppe RT. Long‐term outcome of 525 patients with mycosis fungoides and Sézary syndrome: clinical prognostic factors and risk for disease progression. Archives of Dermatology 2003;139(7):857‐66. [PUBMED: 12873880]

Knobler 2004

Knobler E. Current management strategies for cutaneous T‐cell lymphoma. Clinics in Dermatology 2004;22(3):197‐208. [PUBMED: 15262305]

Koeppel 1994

Koeppel MC, Stoppa AM, Resbeut M, Blaise D, Coignet M, Coulier L, et al. Mycosis fungoides and allogenic bone marrow transplantation. Acta Dermato‐Venereologica 1994;74(4):331‐2. [PUBMED: 7976105]

Kolb 1998

Kolb HJ. Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties. Vox Sanguinis 1998;74(Suppl 2):321‐9. [PUBMED: 9704463]

Kolb 2008

Kolb HJ. Graft‐versus‐leukemia effects of transplantation and donor lymphocytes. Blood 2008;112(12):4371‐83. [PUBMED: 19029455]

Lansigan 2010

Lansigan F, Foss FM. Current and emerging treatment strategies for cutaneous T‐cell lymphoma. Drugs 2010;70(3):273‐86. [PUBMED: 20166766]

Lau 2006

Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333(7568):597‐600.

Lefebvre 2011

Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Ljungman 2010

Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplantation 2010;45(2):219‐34. [PUBMED: 19584824]

Parmar 1998

Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.

RevMan [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.

Ringdén 2009

Ringdén O, Karlsson H, Olsson R, Omazic B, Uhlin M. The allogeneic graft‐versus‐cancer effect. British Journal of Haematology 2009;147(5):614‐33. [PUBMED: 19735262]

Rocha 2009

Rocha V, Mohty M, Gluckman E, Rio B, Eurocord, Reduced‐Intensity Conditioning Subcommittee of the Acute Leukaemia Working Party, French Society of Bone Marrow Transplantation and Cellular Therapy. Reduced‐intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Current Opinion in Oncology 2009;21(Suppl 1):31‐4. [PUBMED: 19561411]

Roddie 2011

Roddie C, Peggs KS. Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation. Expert Opinion on Biological Therapy 2011;11(4):473‐87. [PUBMED: 21269237]

Saunes 2009

Saunes M, Nilsen TI, Johannesen TB. Incidence of primary cutaneous T‐cell lymphoma in Norway. The British Journal of Dermatology 2009;160(2):376‐9. [PUBMED: 18808419]

Stadler 2008

Stadler R, Assaf C, Klemke CD, Nashan D, Weichenthal M, Dummer R, et al. Short German guidelines: cutaneous lymphomas. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2008;6 Suppl 1:S25‐31. [PUBMED: 18801140]

Stang 2006

Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, et al. Incidence of skin lymphoma in Germany. Annals of Epidemiology 2006;16(3):214‐22. [PUBMED: 16019225]

Sterne 2008

Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.

Storb 2009

Storb R. Reduced‐intensity conditioning transplantation in myeloid malignancies. Current Opinion in Oncology 2009;21(Suppl 1):3‐5. [PUBMED: 19561410]

Tierney 2007

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials 2007;8:16.

Vidulich 2009

Vidulich KA, Talpur R, Bassett RL, Duvic M. Overall survival in erythrodermic cutaneous T‐cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T‐cell lymphoma. International Journal of Dermatology 2009;48(3):243‐52. [PUBMED: 19261011]

Wheatley 2004

Wheatley K, Gray R. Commentary: Mendelian randomization‐‐an update on its use to evaluate allogeneic stem cell transplantation in leukaemia. International Journal of Epidemiology 2004;33(1):15‐7. [PUBMED: 15075139]

Whittaker 2003

Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T‐cell lymphomas. The British Journal of Dermatology 2003;149(6):1095‐107. [PUBMED: 14696593]

Whittaker 2007

Whittaker SJ, Foss FM. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sézary syndrome variants of cutaneous T‐cell lymphoma. Cancer Treatment Reviews 2007;33(2):146‐60. [PUBMED: 17275192]

Characteristics of studies

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Alaibac 2005

Case report of a patient with SPTCL treated with autologous PBSCT and review of published cases of SPTCL treated with this therapeutic approach.

Bertz 2002

Study not randomised, not controlled.

CTCL not included.

Burt 2000

Case report of a patient with MF treated with allogeneic haematopoetic stem cell transplantation.

Chanan‐Khan 2004

Case report of a patient with alpha/beta hepatosplenic T‐cell non‐Hodgkin lymphoma treated with allogeneic stem cell transplantation and donor lymphocyte infusion.

Corradini 2006

Patients with MF/SS or cutaneous lymphomas were excluded from the study.

Cudillo 2009

Case report of a patient with SS.

Duarte 2008

Review article of published data on the use of autologous and allogeneic HSCT for CTCL.

Duarte 2010

Study not randomised, not controlled.

Retrospective analysis on the use of alloHSCT in a series of patients with advanced‐stage MF/SS.

Duvic 2010

Study not randomised, not controlled.

Single‐arm study observing safety and efficacy of total skin electron beam with allogeneic stem cell transplantation in 19 patients with CTCL.

Fijnheer 2003

Case report of a patient with cutaneous CD30‐negative large T‐cell lymphoma treated with non‐myeloablative allogeneic peripheral stem cell transplantation.

Gabriel 2007

Case report of a patient with a cytotoxic variant of MF treated with autologous stem cell transplantation followed by reduced‐intensity sibling allogeneic stem cell transplantation in relapsed disease.

Ghobrial 2005

Study not randomised, not controlled.

Retrospective analysis of diverse therapeutic approaches in 21 patients with SPTCL.

Guitart 2002

Study not randomised, not controlled.

Case series of three patients with refractory tumour stage MF treated with allogeneic HLA‐matched sibling transplantation after cytoreductive chemotherapy and total‐body irradiation.

Hamadani 2008

CTCL not included.

Hathaway 2007

Study not randomised, not controlled.

Case series of two patients with SPTCL treated with corticosteroids and denileukin diftitox.

Herbert 2004

Study not randomised, not controlled.

Case series of three patients with advanced, refractory (N = 2) or transformed (N = 1) CTCL who underwent reduced‐intensity allogeneic stem cell transplantation.

Hoff 2008

Case report of a patient with treatment‐refractory MF treated with non‐myeloablative allogeneic stem cell transplantation.

Horwitz 2008

Review article discussing the importance of stage‐based therapy in MF and SS.

Ichii 2006

Case report of a patient with SPTCL treated with allogeneic PBSCT.

Kahata 2008

Case report of a patient with SS with large cell transformation treated with reduced‐intensity allogeneic bone marrow transplantation.

Knobler 2001

Review article about clinical trials of extracorporeal photochemoimmunotherapy (ECP) in CTCL.

Knobler 2002

Case report of a patient with CTCL treated with ECP, including an update on current status of ECP treatment.

Koch 2009

Case report of a patient with cutaneous gamma/delta T‐cell lymphoma treated with allogeneic stem cell transplantation.

Majhail 2005

Review article on the current status of haematopoetic stem cell transplantation in CTCL.

Masood 2002

Case report of a patient with stage IVA MF treated with HLA‐matched allogeneic stem cell transplantation.

Molina 1999

Case report of a patient with refractory SS treated with allogeneic unrelated donor bone marrow transplantation.

Molina 2005

Study not randomised, not controlled.

Retrospective analysis of eight patients with advanced MF/SS evaluating the outcome of allogeneic haematopoetic stem cell transplantation in these patients.

Mukai 2003

Case report of a patient with SPTCL treated with high‐dose chemotherapy and total body irradiation with autologous peripheral stem cell rescue.

Nakahashi 2009

Case report of a patient with refractory SPTCL treated with autologous peripheral blood stem cell transplantation.

Nishio 2000

Case report of a patient with CD30‐negative T‐cell lymphoma treated with autologous peripheral blood stem cell transplantation.

Okada 2010

Case report of a patient with MF treated with allogeneic bone marrow transplantation followed by relapse with a therapy‐resistant immunophenotypic change (CD4+ to CD8+).

Perez‐Persona 2006

Case report.

Patient did not fit inclusion criteria (aged 15).

Poligone 2010

Review article about the use of innovative therapies for CTCL.

Rook 1994

Review article on the general use of extracorporeal photopheresis.

Russell‐Jones 2001

Study not randomised, not controlled.

Single‐arm study observing the efficacy of autologous peripheral stem cell transplantation in nine patients with MF.

Shustov 2010

Study not randomised, not controlled.

Single‐arm study evaluating the outcome after non‐myeloablative alloHSCT for patients with advanced T‐cell and NK‐cell lymphoma.

Soligo 2003

Study not randomised, not controlled.

Case series of three patients with advanced MF treated with HLA‐identical non‐myeloablative allogeneic stem cell transplantation.

Taylor 1992

Review article on the general use of extracorporeal photochemotherapy.

Tsuji 2010

Case series of two patients with MF treated by reduced‐intensity cord blood transplantation.

Wu 2009

Meta‐analysis of 39 patients to compare the outcome of allogeneic versus autologous stem cell transplantation in patients with MF/SS.

Zain 2010

Review article about epigenetic therapies in cutaneous T‐cell lymphomas.

Only studies thought to be potentially suitable for this review are mentioned in this table.

CTCL ‐ cutaneous T‐cell lymphoma

HLA ‐ human leukocyte antigen

HSCT ‐ haematopoetic stem cell transplantation

MF ‐ Mycosis fungoides

PBSCT ‐ peripheral blood stem cell transplantation

SPTCL ‐ subcutaneous panniculitis‐like T‐cell lymphoma

SS ‐ Sézary syndrome

Update 2013
Figuras y tablas -
Figure 1

Update 2013

Ir a la figura de la revisiónAbrir en una pestaña nueva